Design, Synthesis, and Antitumor Activity of Isoliquiritigenin Amino Acid Ester Derivatives

被引：1

作者：

Liu, Chi ^{[1
]}

Liu, Xinyue ^{[1
]}

Ma, Qing ^{[1
]}

Su, Fengyan ^{[1
]}

Cai, Enbo ^{[1
]}

机构：

[1] Jilin Agr Univ, Coll Chinese Med Mat, 2888 Xincheng St, Changchun 130118, Jilin, Peoples R China

来源：

MOLECULES | 2024年 / 29卷 / 11期

关键词：

isoliquiritigenin derivatives; cervical cancer; antitumor; PI3K/Akt/mTOR signaling pathway; CANCER; CHALLENGES; APOPTOSIS;

D O I：

10.3390/molecules29112641

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Isoliquiritigenin (ISL) is a chalcone that has shown great potential in the treatment of cancer. However, its relatively weak activity and low water solubility limit its clinical application. In this study, we designed and synthesized 21 amino acid ester derivatives of ISL and characterized the compounds using 1H NMR and 13C NMR. Among them, compound 9 (IC50 = 14.36 mu M) had a better inhibitory effect on human cervical cancer (Hela) than ISL (IC50 = 126.5 mu M), and it was superior to the positive drug 5-FU (IC50 = 33.59 mu M). The mechanism of the action experiment showed that compound 9 could induce Hela cell apoptosis and autophagy through the PI3K/Akt/mTOR pathway.

引用

页数：18

共 30 条

[1] A review of the pharmacological and therapeutic effects of auraptene [J].

Bibak, Bahram ;

Shakeri, Farzaneh ;

Barreto, George E. ;

Keshavarzi, Zakieh ;

Sathyapalan, Thozhukat ;

Sahebkar, Amirhossein .

BIOFACTORS, 2019, 45 (06) :867-879

[2]

[Anonymous], 2020, CA Cancer J Clin, V70, P313, DOI [10.3322/caac.21492, 10.3322/caac.21609]

[3] Synthesis and antitumour activity of arctigenin amino acid ester derivatives against H22 hepatocellular carcinoma [J].

Cai, Enbo ;

Guo, Shijie ;

Yang, Limin ;

Han, Mei ;

Xia, Jing ;

Zhao, Yan ;

Gao, Xiaorui ;

Wang, Yu .

NATURAL PRODUCT RESEARCH, 2018, 32 (04) :406-411

[4] An overview of autophagy: Mechanism, regulation and research progress [J].

Cao, Weiya ;

Li, Jinhong ;

Yang, Kepeng ;

Cao, Dongli .

BULLETIN DU CANCER, 2021, 108 (03) :304-322

[5] Isoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases [J].

Chen, Ziyi ;

Ding, Wenwen ;

Yang, Xiaoxue ;

Lu, Tiangong ;

Liu, Ying .

JOURNAL OF ETHNOPHARMACOLOGY, 2024, 318

[6] Drug Resistance Reversal Potential of Isoliquiritigenin and Liquiritigenin Isolated from Glycyrrhiza glabra Against Methicillin-Resistant Staphylococcus aureus (MRSA) [J].

Gaur, Rashmi ;

Gupta, Vivek Kumar ;

Singh, Pooja ;

Pal, Anirban ;

Darokar, Mahendra Padurang ;

Bhakuni, Rajendra Singh .

PHYTOTHERAPY RESEARCH, 2016, 30 (10) :1708-1715

[7] Challenges, Applications, and Recent Advances of Protein-Ligand Docking in Structure-Based Drug Design [J].

Grinter, Sam Z. ;

Zou, Xiaoqin .

MOLECULES, 2014, 19 (07) :10150-10176

[8] Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress [J].

Gu, Xuemei ;

Shi, Yujuan ;

Chen, Xiaojun ;

Sun, Zijia ;

Luo, Wu ;

Hu, Xiang ;

Jin, Ge ;

You, Shengban ;

Qian, Yuanyuan ;

Wu, Wenjun ;

Liang, Guang ;

Wu, Gaojun ;

Chen, Zimiao ;

Chen, Xiong .

PHYTOMEDICINE, 2020, 78

[9] Targeting PI3K/Akt signal transduction for cancer therapy [J].

He, Yan ;

Sun, Miao Miao ;

Zhang, Guo Geng ;

Yang, Jing ;

Chen, Kui Sheng ;

Xu, Wen Wen ;

Li, Bin .

SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)

[10] Isoliquiritigenin inhibits cell proliferation and induces apoptosis in human hepatoma cells [J].

Hsu, YL ;

Kuo, PL ;

Lin, LT ;

Lin, CC .

PLANTA MEDICA, 2005, 71 (02) :130-134

← 1 2 3 →